Nipocalimab
DrugWikipedia
7
MENTIONS
7
EPISODES
7
PODCASTS
Search complete. 7 mentions across 7 episodes found for "Nipocalimab".
Oct 5, 2026
Tuan H. VuGUEST
Uh, for Rozly, um, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuGUEST
Uh, nipco- nipocalimab is a, a drug that has to be administered, uh, every two weeks.
Tuan H. VuGUEST
Uh, regarding efgartigimod, uh, the drug was first tested, tested in the ADAPT trial, uh, with the IV formulation, and you can see that, um, with treatment, um, there's a separation fairly early and that, uh, peak around, uh, week four, which is one week after the, uh, fourth dose.
Tuan H. VuGUEST
Uh, and then, um, after that, the patients, um, tend to Um, have recurrent, uh, symptoms back to baseline.
Tuan H. VuGUEST
Uh, for Rozly, um, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuGUEST
Uh, nipoc-nipocalimab is a, a drug that has to be administered, uh, every two weeks.
Tuan H. VuGUEST
Uh, regarding efgartigimod, uh, the drug was first tested, tested in the ADAPT trial, uh, with the IV formulation, and you can see that, um, with treatment, um, there's a separation fairly early and that, uh, peak around, uh, week four, which is one week after the, uh, fourth dose.
Tuan H. VuGUEST
Uh, and then, um, after that, the patients, um, tend to, um, have recurrent, uh, symptoms back to baseline.
Tuan H. VuGUEST
For ROSI, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuGUEST
Nipocalimab is a drug that
speaker_0NARRATOR
has to be administered every two weeks.
Tuan H. VuGUEST
Regarding Avgatigamon, the drug was first tested in the ADAPT trial with the IV formulation.
Tuan H. VuHOST
Uh, for Rozly, um, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuHOST
Uh, nipoc-nipocalimab is a, a drug that has to be administered, uh, every two weeks.
Tuan H. VuHOST
Uh, regarding efgartigimod, uh, the drug was first ted-tested in the Adapt trial, uh, with the IV formulation, and you can see that, um, with treatment, um, there's a separation fairly early and that, uh, peak around, uh, week four, which is one week after the, uh, fourth dose.
Tuan H. VuHOST
Uh, and then, um, after that, the patients, um, tend to, um, have recurrent, uh, symptoms back to baseline.
Tuan H. VuGUEST
Uh, for Rozly, um, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuGUEST
Uh, nipoc- nipocalimab is a drug that has to be administered, uh, every two weeks.
Tuan H. VuGUEST
Uh, regarding efgartigimod, uh, the drug was first ted-tested in the ADAPT trial, uh, with the IV formulation.
Tuan H. VuGUEST
And you can see that, um, with treatment, um, there's a separation fairly early and that, uh, peak around, uh, week four, which is one week after the, uh, fourth dose.
Tuan H. VuGUEST
For ROSI, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan H. VuGUEST
Nipocalimab is a drug that
speaker_0NARRATOR
has to be administered every two weeks.
Tuan H. VuGUEST
Regarding Avgatigamon, the drug was first tested in the ADAPT trial with the IV formulation.
Tuan VuGUEST
For ROSI, it is still given in cycles, and the guidance is to wait four weeks in between cycles, although that can be altered based on your clinical judgment.
Tuan VuGUEST
Nipocalimab is a drug that
speaker_0NARRATOR
has to be administered every two weeks.
Tuan VuGUEST
Regarding Avgatigamon, the drug was first tested in the ADAPT trial with the IV formulation.